Benchmarking nurse outcomes in Australian Magnet® hospitals: cross-sectional survey

por Stone, L., Arneil, M., Coventry, L., Casey, V., Moss, S., Cavadino, A., Laing, B., McCarthy, AL
Publicado 2019

High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides

por Yang, B., Ming, X., Cao, C., Laing, B., Yuan, A., Porter, M. A., Hull-Ryde, E. A., Maddry, J., Suto, M., Janzen, W. P., Juliano, R. L.
Publicado 2015

Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

por Georgiadis, A, Duran, Y, Ribeiro, J, Abelleira-Hervas, L, Robbie, S J, Sünkel-Laing, B, Fourali, S, Gonzalez-Cordero, A, Cristante, E, Michaelides, M, Bainbridge, J W B, Smith, A J, Ali, R R
Publicado 2016

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

por Georgiadis, A., Duran, Y., Ribeiro, J., Abelleira-Hervas, L., Robbie, S. J., Sünkel-Laing, B., Fourali, S., Gonzalez-Cordero, A., Cristante, E., Michaelides, M., Bainbridge, J. W. B., Smith, A. J., Ali, R. R.
Publicado 2018

Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women’s Wellness After Breast Cancer (YWWACP) lifestyle intervention

por Sharples, K., Vear, N. K., Porter-Steele, J., Anderson, D. J., Moeke-Maxwell, T. H., Laing, B. B., Young, L., Bailey, T. G., Benge, S., Huang, Y., Crowley, E., Day, R., Cartwright, R., Findlay, M., Porter, D., Kuper, M., Campbell, I., McCarthy, A. L.
Publicado 2022